Bioptron AG, Switzerland. Company Information.

Part of the Zepter Group from 1996, Bioptron AG is a Swiss company that develops and manufactures medically certified light therapy devices.

Since its incorporation in 1988, BIOPTRON^® has become a global brand that stands for innovative medical healthcare products, unrivalled in prevention, treatment and recovery in various medical conditions. BIOPTRON AG continues to invest in sophisticated research and new product development necessary to achieve optimal clinical effectiveness of light therapy treatments.

Our Headquarter in Wollerau, Switzerland

The Zepter Group

7 factories

5 continents

60 countries

Over 80,000,000 satisfied users

Over 760,000,000 products sold

BIOPTRON^® worldwide

Over 60 countries

Over 30 years on the international market

Over 3,000,000 devices sold

Our mission

Our mission is to empower people to self-care by taking charge of their everyday health and the health of their loved ones. We provide safe, convenient and effective health solutions to treat illness and improve lives.

With our innovative products, we contribute to finding solutions to some of the major challenges of the modern civilization.

Research & development

Years of experience and research have confirmed the positive effects of BIOPTRON^® Hyperlight Therapy and have led to its use in the treatment of a wide range of medical conditions. The therapy with medically certified Hyperlight is now recognized worldwide as a new and innovative form of treatment for the prevention and healing of various medical conditions.

BIOPTRON AG’s team of engineers, scientists, doctors and other specialists are constantly working on further product development necessary to achieve optimal clinical effectiveness of medical light therapy.

Quality certification

BIOPTRON AG in-house laboratories are constantly engaged in the testing and optimization of BIOPTRON^® devices in line with the latest scientific studies carried out by independent institutions. Simultaneously, BIOPTRON^® devices are further certified by accredited, independent testing institutions. Our business processes, including R&D, supplier evaluation, the supply of components to production, ongoing inspections and the production of all devices, comply with the European Community medical directive 93/42/EEC as well as with specific local market regulations.

FDA 510 (k) clearance for pain

For further information visit "510(k) Premarket Notification Database" Our 510(k) No: K032216

510 (k) clearance for pain

Search

BIOPTRON AG, SWITZERLAND